Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131880) titled 'Comparison of the efficacy and safety of Eravacycline and Sulbactam combined with polymyxin in the treatment of CRAB pneumonia' on Sept. 7.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: The Affiliated Hospital of Xuzhou Medical University
Condition:
Carbapenem-Resistant Acinetobacter baumannii Pneumonia
Intervention:
eravacycline combined with polymyxin group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-10
Target Sample Size: eravacycline combined with polymyxin group:30;Sultamicillin Combined with Polymyxin Group:50;
Cou...